Dimethyl Sulfoxide → HCID 11641110, compound
Reaction equation
C(Cl)(=O)C(Cl)=O.[CH3:7][S:8]([CH3:10])=O.[F:11][C:12]([F:17])([F:16])[C:13]([OH:15])=[O:14].[OH:18][CH2:19]/[C:20](/[CH3:50])=[CH:21]/[C@@H:22]([N:26]([CH3:49])[C:27](=[O:48])[C@@H:28]([NH:33][C:34](=[O:47])[C@@H:35]([NH:45][CH3:46])[C:36]([CH3:44])([C:38]1[CH:43]=[CH:42][CH:41]=[CH:40][CH:39]=1)[CH3:37])[C:29]([CH3:32])([CH3:31])[CH3:30])[CH:23]([CH3:25])[CH3:24].C(N(CC)CC)C>ClCCl>[F:11][C:12]([F:17])([F:16])[C:13]([OH:15])=[O:14].[CH3:7][S+:8]([CH3:10])[C:41]1[CH:42]=[CH:43][C:38]([C:36]([CH3:44])([CH3:37])[C@@H:35]([C:34]([NH:33][C@H:28]([C:27]([N:26]([C@@H:22]([CH:23]([CH3:24])[CH3:25])/[CH:21]=[C:20](\[CH3:50])/[CH:19]=[O:18])[CH3:49])=[O:48])[C:29]([CH3:30])([CH3:32])[CH3:31])=[O:47])[NH:45][CH3:46])=[CH:39][CH:40]=1.[CH3:46][NH:45][C@H:35]([C:34]([NH:33][C@H:28]([C:27]([N:26]([C@@H:22]([CH:23]([CH3:25])[CH3:24])/[CH:21]=[C:20](\[CH3:50])/[CH:19]=[O:18])[CH3:49])=[O:48])[C:29]([CH3:32])([CH3:31])[CH3:30])=[O:47])[C:36]([CH3:44])([CH3:37])[C:38]1[CH:43]=[CH:42][CH:41]=[CH:40][CH:39]=1Participants
Conditions
- Temperature
- 25 °C
Procedure
Following the procedure described in J. Org. Chem. 1994, 59(7), 1771, to a solution of oxalyl chloride (0.17 mmol) in dichloromethane at −78° C. is added a solution of dimethylsulfoxide (0.348 mmol, 0.025 mL) in dichloromethane dropwise. After 10 min a solution of (2S)-N-[(1S,2E)-4-hydroxy-1-isopropyl-3-methyl-2-butenyl]-N,3,3-trimethyl-2-{[(2S)-3-methyl-2-(methylamino)-3-phenylbutanoyl]amino}butanamide trifluoroacetic acid (83 mg, from Example 81) in dichloromethane is added dropwise. After 20 min triethylamine (0.725 mmol, 0.1 mL) is added dropwise. The reaction mixture is allowed to warm to 25° C. then washed with water and dried over anhydrous sodium sulfate. Concentration in vacuo and purification by reverse phase HPLC (0.01% aqueous trifluoroacetic acid/acetonitrile gradient system) gave the trifluoracetic acid salt of N,β,β-trimethyl-L-phenylalanyl-N1-[(1S,2E)-1-isopropyl-3-methyl-4-oxo-2-butenyl]-N1,3-dimethyl-L-valinamide as a white powder (43 mg) MS (ES): m/z 458.1 (M+H) and 4-(dimethylsulfonio)-N,β,β-trimethyl-L-phenylalanyl-N1-[(1S,2E)-1-isopropyl-3-methyl-4-oxo-2-butenyl]-N1,3-dimethyl-L-valinamide trifluoroacetate as a clear glass (28 mg) MS (ES): m/z 518.0 (M+).
Workup
- washthen washed with water
- dry with materialdried over anhydrous sodium sulfate
- concentrationConcentration
- customin vacuo and purification by reverse phase HPLC (0.01% aqueous trifluoroacetic acid/acetonitrile gradient system)
Sources & evidence
- ORD record
- ord-f43a353e142d4020b8c88992cc2bdcf6
- Source dataset
- uspto-grants-2009_12
- Patent number
- US07626023B2
Reaction notes
Loading…